New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 24, 2014
04:55 EDTEW, EW, EW, EW, EW, QDEL, QDEL, QDEL, QDEL, QDEL, SQNM, SQNM, SQNM, SQNM, SQNM, TNDM, TNDM, TNDM, TNDM, TNDM, VOLC, VOLC, VOLC, VOLC, VOLC, ATEC, ATEC, ATEC, ATEC, ATEC, CFN, CFN, CFN, CFN, CFN, ICUI, ICUI, ICUI, ICUI, ICUI, IART, IART, IART, IART, IART, ELGX, ELGX, ELGX, ELGX, ELGX, NUVA, NUVA, NUVA, NUVA, NUVAPiper Jaffray to hold a bus tour
7th Annual SoCal Medtech & Diagnostics Bus Tour to travel throughout San Diego on August 25-28.
News For EW;ELGX;IART;ICUI;CFN;ATEC;VOLC;TNDM;SQNM;QDEL;NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 18, 2014
11:00 EDTELGXEndologix to host investor meeting
Subscribe for More Information
07:11 EDTELGXEndologix completes patient enrollment in Nellix EVAS FORWARD-IDE clinical trial
Endologix announced that it has completed patient enrollment in the EVAS FORWARD-IDE clinical trial, the company's U.S. pivotal clinical trial designed to evaluate the safety and effectiveness of the Nellix EndoVascular Aneurysm Sealing System for the endovascular repair of infrarenal abdominal aortic aneurysms, or AAA. Primary endpoint analysis results at one-year and beyond will be used to support the company's premarket approval, or PMA, application to the FDA for the Nellix EVAS System. The EVAS FORWARD-IDE clinical trial enrolled 179 patients at 29 centers in the U.S. and Europe. Enrollment under an extended investigation phase is anticipated to begin shortly and will continue during the pivotal trial follow-up period and PMA preparation/review process. Based on current assumptions and timelines, the company anticipates FDA approval of the Nellix System in the U.S. before the end of 2016.
November 17, 2014
10:02 EDTNUVA, VOLCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CyrusOne (CONE) upgraded to Buy from Hold at Stifel... MGIC Investment (MTG) upgraded to Conviction Buy from Buy at Goldman... NuVasive (NUVA) upgraded to Outperform from Market Perform at Wells Fargo... Phillips 66 (PSX) upgraded to Outperform from Neutral at Credit Suisse... Pinnacle Foods (PF) upgraded to Buy from Hold at Deutsche Bank... Rayonier (RYN) upgraded to Outperform from Sector Perform at RBC Capital.. Thoratec (THOR) upgraded to Outperform from Market Perform at Wells Fargo... Volcano (VOLC) upgraded to Outperform from Neutral at Credit Suisse... Progressive Waste (BIN) upgraded to Neutral from Underperform at Macquarie... Clean Harbors (CLH) upgraded to Outperform from Neutral at Wedbush... McGraw Hill Financial (MHFI) upgraded to Buy from Hold at Benchmark Co... Chesapeake (CHK) upgraded to Outperform from Market Perform at Bernstein... American Science & Engineering (ASEI) upgraded to Fair Value from Sell at CRT Capital... Sony (SNE) upgraded to Overweight from Equal Weight at Morgan Stanley.
05:49 EDTVOLCVolcano upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
05:39 EDTNUVANuVasive upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo upgraded NuVasive to Outperform after attending last week's North American Spine Society annual meeting. Wells believes the worldwide spine market continues to improve and that NuVasive is well positioned to capitalize on the momentum. The firm raised its price target range for shares to $50-$52 from $43-$44.
November 14, 2014
08:59 EDTNUVANuVasive price target raised to $51 from $49 at Canaccord
Subscribe for More Information
November 13, 2014
08:39 EDTIARTIntegra LifeSciences announces FDA clearance for spinal fusion procedures
Subscribe for More Information
November 12, 2014
07:27 EDTNUVA, ATEC, CFNNorth American Spine Society to hold annual meeting
Subscribe for More Information
07:22 EDTQDELAssociation of Molecular Pathology is holding annual meeting
2014 Annual Meeting of AMP is being held in National Harbor, Maryland on November 12-15.
November 11, 2014
12:46 EDTICUIOn The Fly: Midday Wrap
Stocks on Wall Street were little changed at midday, as the light economic calendar and bond markets being closed in observance of Veteran's Day make for a quiet tone to the market. The averages have remained close to the flat line throughout the morning, as the major averages undergo a day of consolidation near their record levels. ECONOMIC EVENTS: In the U.S., the National Federation of Independent Business' small business optimism index came in at 96.1, which was up from the prior 95.3 figure and roughly matched the consensus forecast. In Asia, Japan's Prime Minister Shinzo Abe said that the country's intended second sales tax hike will be delayed, according to government sources cited by Reuters. COMPANY NEWS: Chinese e-commerce giant Alibaba (BABA) generated record sales during the Chinese Singles Day holiday and a number of research firms initiated coverage of the stock with upbeat notes. Alibaba stated on its official corporate news Twitter feed that its final Singles Day shopping festival gross merchandise volume exceeded $9.3B and the company's Executive Chairman Jack Ma made headlines by stating that the company's Alipay finance services arm will "definitely" go public. Additionally, Oppenheimer initiated coverage of Alibaba with an Outperform rating in a note to investors last night and HSBC earlier today initiated coverage of Alibaba with an Overweight rating and a Street-high price target of $148 per share. Despite all of this, the stock appeared to have a "sell-the-news" reaction to the Singles Day event, as its shares fell about 3% in midday trading. MAJOR MOVERS: Among the notable gainers was Rackspace (RAX), which rallied 13.5% after the cloud computing service provider reported better than expected third quarter results and announced a $500M share repurchase plan. Also higher was ICU Medical (ICUI), which rose 14% and was upgraded at Roth Capital and Piper Jaffray following its second consecutive better than expected quarterly report. Among the noteworthy losers was Vivint Solar (VSLR), which tumbled over 21% after the company reported steeper than expected losses in its first quarterly report since coming public last month. Also lower following its first earnings report since coming public was e-commerce home goods retailer Wayfair (W), which dropped 13% despite posting revenues that beat the consensus forecast and Pacific Crest and Wells Fargo making positive comments on its results. INDEXES: Near midday, the Dow was down 9.89, or 0.06%, to 17,603.85, the Nasdaq was up 1.67, or 0.04%, to 4,653.29, and the S&P 500 was little changed at 2,038.15.
10:00 EDTNUVA, ICUIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alcentra Capital (ABDC) upgraded to Outperform from Market Perform at Keefe Bruyette... Ambac Financial (AMBC) upgraded to Neutral from Sell at MKM Partners... Banco Bilbao (BBVA) upgraded to Buy from Reduce at Nomura... Darden (DRI) upgraded at KeyBanc... ICU Medical (ICUI) upgraded to Overweight from Neutral at Piper Jaffray... IMAX (IMAX) upgraded to Buy from Neutral at Goldman... Juniper (JNPR) upgraded to Buy from Neutral at Nomura... Michaels (MIK) upgraded to Overweight from Equal Weight at Morgan Stanley... Midcoast Energy (MEP) upgraded to Outperform from Neutral at Credit Suisse... Midstates Petroleum (MPO) upgraded to Outperform from Market Perform at Northland... Monroe Capital (MRCC) upgraded to Outperform from Neutral at RW Baird... NuVasive (NUVA) upgraded to Outperform from Market Perform at Cowen... ONEOK Partners (OKS) upgraded to Outperform from Neutral at Credit Suisse... ORBCOMM (ORBC) upgraded to Overweight from Equal Weight at First Analysis... Pattern Energy (PEGI) upgraded to Outperform from Neutral at Macquarie... Targa Resources Partners (NGLS) upgraded to Outperform from Neutral at Credit Suisse... Time Warner (TWX) upgraded to Conviction Buy from Neutral at Goldman... Tremor Video (TRMR) upgraded to Buy from Hold at Jefferies... Western Gas Partners (WES) upgraded to Outperform from Neutral at Credit Suisse... Yamana Gold (AUY) upgraded to Overweight from Neutral at HSBC... Zynga (ZNGA) upgraded to Buy from Hold at Jefferies.
08:10 EDTNUVANuVasive upgraded to Outperform from Market Perform at Cowen
As previously reported, Cowen upgraded NuVasive to Outperform from Market Perform. The analyst believes NuVasive is well positioned for share gains from innovative offerings and to beat modestly improving Spine market growth rates. Price target raised to $51 from $44.
07:51 EDTNUVANuVasive upgraded to Outperform from Market Perform at Cowen
06:24 EDTICUIICU Medical upgraded to Buy from Neutral at Roth Capital
Roth Capital upgraded ICU Medical to Buy following the Q3 report and guidance citing improved commercial execution in 2015 and operating leverage driven by operational and cost efficiency initiatives. Price target raised to $82 from $55.
05:31 EDTICUIICU Medical upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
November 10, 2014
16:24 EDTICUIICU Medical raises FY14 adjusted EPS view to $2.25-$2.33 from $1.95-$2.15
Subscribe for More Information
16:22 EDTICUIICU Medical raises FY14 outlook
Subscribe for More Information
16:21 EDTICUIICU Medical reports Q3 adjusted EPS 66c, consensus 48c
Subscribe for More Information
13:54 EDTNUVANuVasive to host investor meeting
Subscribe for More Information
07:57 EDTQDELQuidel price target raised to $34 from $30 at Canaccord
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use